The Gauss/Cellex rapid at-home COVID-19 test. Credit: Gauss

Gauss, a computer vision startup, and Cellex, a biotech company that works on diagnostics, are announcing the first rapid COVID-19 test that can be fully performed by people at home without involving a laboratory.

Why it matters: Experts agree that the U.S. still needs far more widespread testing to help contain the coronavirus pandemic. An antigen test that could be performed and provide results rapidly at home could help reduce testing delays and allow people to quickly find out whether they need to isolate because of a COVID-19 infection.

How it works: In the antigen test, which was developed by Cellex, a user will take a nasal swab to both nostrils, and then place the swab in a small vial filled with a buffer solution.

  • Four droplets from the tube are placed on a rapid test cassette, and test lines will show up of varying intensity, based on whether and how much virus is in the sample.
  • Users will then take a picture of the rapid test, and Gauss's app will use AI to deliver back the results — all within 15 minutes.

Of note: While other rapid diagnostics have been developed that allow users to test themselves at home, those earlier methods still required people to send in samples to a lab or health facility for processing.

  • The Gauss/Cellex diagnostic would be the first test that can be done to completion at home.
  • Cellex CEO James Li says the test demonstrates nearly 90% sensitivity — how often a test generates a correct positive result — compared to PCR tests, and nearly 100% specificity, or how often it produces a correct negative result.
What is important for COVID-19 pandemic management is that this is a tool that will allow people to self-monitor and self-isolate.
— James Li

What to watch: Whether the FDA gives the new test an Emergency Use Authorization, which would allow it to more rapidly come to market.

  • There's also the question of price, although Li says that "our goal is to make this assay as widely available as possible."

The bottom line: Quick and easy at-home tests would certainly help reduce the spread of COVID-19, and they show how the pandemic has accelerated the coming of distributed medicine.

Go deeper

Updated 20 hours ago - Health

World coronavirus updates

Expand chart
Data: The Center for Systems Science and Engineering at Johns Hopkins; Map: Axios Visuals

India became on Monday the second country after the U.S. to surpass 6 million cases.

By the numbers: Globally, nearly 997,800 people have died from COVID-19 and over 33 million have tested positive, Johns Hopkins data shows.

Caitlin Owens, author of Vitals
17 hours ago - Health

Why kids get less severe coronavirus infections

Photo by Bruce Bennett/Getty Images

A new study suggests that the reason why children get less severe coronavirus infections than adults is because they have a different immune response, NYT reports.

What they're saying: "The bottom line is, yes, children do respond differently immunologically to this virus, and it seems to be protecting the kids," Betsy Herold, a pediatric infectious disease expert at Albert Einstein College of Medicine who led the study, told the Times.

23 hours ago - World

India's coronavirus cases top 6 million

A health worker checks vitals of a coronavirus patient inside the Commonwealth Games Village Covid Care Centre, in New Delhi, India, on Sunday. Photo: Sanjeev Verma/Hindustan Times via Getty Images

India's Ministry of Health confirmed the country's coronavirus case numbers surpassed 6 million on Monday after reporting 82,170 new infections in 24 hours.

Why it matters: India is the second country after the U.S. to hit 6 million cases. The South Asian country's COVID-19 tally hit 5 million on Sept. 16 and 4 million on Sept. 4. The ministry said that over 5 million Indian residents have recovered from the virus. But, AP notes, "New infections in India are currently being reported faster than anywhere else in the world."

Editor's note: This article has been updated with new details throughout.